Fulin Wang , Peng Yao , Haifang Yu , Lu Gan , Yu Cao
{"title":"Circadian regulation of vascular function: Metabolism as a link from molecular mechanisms to clinical implications","authors":"Fulin Wang , Peng Yao , Haifang Yu , Lu Gan , Yu Cao","doi":"10.1016/j.bbadis.2025.168048","DOIUrl":null,"url":null,"abstract":"<div><div>Circadian rhythms act as central coordinators of vascular physiology, synchronizing metabolic and hemodynamic processes across different vascular beds. Cell-autonomous clocks dynamically regulate vascular functions, including vasodilation and inflammatory responses, in endothelial cells, smooth muscle cells, and fibroblasts. Emerging evidence indicates extensive crosstalk with metabolic cell death pathways, particularly lipophagy-mediated lipid turnover, redox stress-triggered disulfidptosis, and glucotoxicity-induced metabolic collapse, all of which display circadian rhythmicity. Disruption of these pathways, such as in shift workers or individuals carrying clock gene mutation, significantly increases the risk of hypertension, atherosclerosis, and microvascular dysfunction. In this review, we highlight translational strategies that leverage circadian biology, including chronotherapy, pharmacological modulation of core circadian clock components, light-dark synchronization, and lifestyle interventions. We also emphasize that future research should aim to decode the spatiotemporal regulation of circadian-metabolic networks, which may offer novel insights for precision medicine approaches targeting vascular metabolic disorders.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1872 1","pages":"Article 168048"},"PeriodicalIF":4.2000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et biophysica acta. Molecular basis of disease","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0925443925003965","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Circadian rhythms act as central coordinators of vascular physiology, synchronizing metabolic and hemodynamic processes across different vascular beds. Cell-autonomous clocks dynamically regulate vascular functions, including vasodilation and inflammatory responses, in endothelial cells, smooth muscle cells, and fibroblasts. Emerging evidence indicates extensive crosstalk with metabolic cell death pathways, particularly lipophagy-mediated lipid turnover, redox stress-triggered disulfidptosis, and glucotoxicity-induced metabolic collapse, all of which display circadian rhythmicity. Disruption of these pathways, such as in shift workers or individuals carrying clock gene mutation, significantly increases the risk of hypertension, atherosclerosis, and microvascular dysfunction. In this review, we highlight translational strategies that leverage circadian biology, including chronotherapy, pharmacological modulation of core circadian clock components, light-dark synchronization, and lifestyle interventions. We also emphasize that future research should aim to decode the spatiotemporal regulation of circadian-metabolic networks, which may offer novel insights for precision medicine approaches targeting vascular metabolic disorders.
期刊介绍:
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.